[Lipid disorders in non-insulin dependent diabetes--principles of treatment].

Abstract

Hyperlipoproteinemia is one of the main coronary risk factors. Lipid metabolism disorders occur in about 40-60% of patients with NIDDM. Hyperlipidemia in diabetics is related to diabetes control, presence of diabetic nephropathy, diet, some drugs and genetic factors. Lipid metabolism disorders in NIDDM comprise qualitative changes--usually increase of serum triglyceride concentration and decrease of HDL--cholesterol, and qualitative changes of lipoprotein composition, glycation and oxidation. The first steps of hypolipemic therapy are good control of diabetes, reduction of overweight, hypolipidemic diet, and if a goal level is not achieved--farmacotherapy. Hypolipidemic treatment should be relevant in reduction of cardiovascular diseases in diabetic patients.

• Authors: B Idzior-Waluś
• Journal: Przeglad lekarski (Przegl Lek) Vol. 53 Issue 9 Pg. 653-9 ( 1996) ISSN: 0033-2240 [Print] Poland
• Vernacular Title: Zaburzenia lipidowe w cukrzycy nieinsulinozaleznej--zasady leczenia.
• PMID: 8992531 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Cholesterol, HDL
• Triglycerides

Topics

• Cholesterol, HDL (blood)
• Coronary Disease (etiology, prevention & control)
• Diabetes Mellitus, Type 2 (complications, metabolism, therapy)
• Humans
• Hyperlipidemias (complications, metabolism, therapy)
• Hyperlipoproteinemias (complications)
• Triglycerides (blood)